Different fates of alzheimer's disease amyloid-β fibrils remodeled by biocompatible small molecules

Biomacromolecules

Volumn 14, Issue 1, 2013, Pages 264-274

  Irwin, Jacob A ^a   Wong, H Edward ^a   Kwon, Inchan ^a,b  

^a University of Virginia   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S DISEASE; AMYLOID FIBRIL; AMYLOID FIBRIL FORMATION; BRILLIANT BLUE; COMPARATIVE STUDIES; FIBRILLAR STRUCTURES; HUMAN DISEASE; METHYLENE BLUE; MOLECULAR MECHANISM; PHYSIOLOGICAL ENVIRONMENT; PROTOFIBRILS; SMALL MOLECULES; STRUCTURAL FEATURE; TRANSMISSION ELECTRON MICROSCOPY TEM;

AGGREGATES; AROMATIC COMPOUNDS; ATOMIC FORCE MICROSCOPY; MOLECULES; PHYSIOLOGY; TRANSMISSION ELECTRON MICROSCOPY;

GLYCOPROTEINS;

AMYLOID; AMYLOID BETA PROTEIN; BIOMATERIAL; BRILLIANT BLUE G; ERYTHROSINE; METHYLENE BLUE; NANOMATERIAL; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; ATOMIC FORCE MICROSCOPY; CHEMICAL STRUCTURE; CIRCULAR DICHROISM; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN AGGREGATION; TRANSMISSION ELECTRON MICROSCOPY;

ALZHEIMER DISEASE; AMYLOID; BIOCOMPATIBLE MATERIALS; CIRCULAR DICHROISM; HUMANS; MICROSCOPY, ATOMIC FORCE; PROTEIN CONFORMATION;

EID: 84872503847     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm3016994     Document Type: Article

References (76)

1. Hardy, J.; Higgins, G. Alzheimer's Disease: The Amyloid Cascade Hypothesis Science 1992, 256, 184-185
2. Li, J.; Uversky, V. N.; Fink, A. L. Effect of Familial Parkinson's Disease Point Mutations A30P and A53T on the Structural Properties, Aggregation, and Fibrillation of Human α-Synuclein Biochemistry 2001, 40 (38) 11604-11613
3. Li, J.; Zhu, M.; Rajamani, S.; Uversky, V. N.; Fink, A. L. Rifampicin Inhibits α-Synuclein Fibrillation and Disaggregates Fibrils Chem. Biol. (Cambridge, MA, U. S.) 2004, 11 (11) 1513-1521
4. Spillantini, M. G.; Crowther, R. A.; Jakes, R.; Cairns, N. J.; Lantos, P. L.; Goedert, M. Filamentous α-Synuclein Inclusions Link Multiple System Atrophy with Parkinson's Disease and Dementia with Lewy Bodies Neurosci. Lett. 1998, 251 (3) 205-208
5. Gregoire, S.; Irwin, J.; Kwon, I. Techniques for Monitoring Protein Misfolding and Aggregation in Vitro and in Living Cells Korean J. Chem. Eng. 2012, 29 (6) 693-702
6. Jahn, T. R.; Radford, S. E. The Yin and Yang of Protein Folding FEBS J. 2005, 272 (23) 5962-5970
7. Jones, O. G.; Mezzenga, R. Inhibiting, Promoting, and Preserving Stability of Functional Protein Fibrils Soft Matter 2012, 8 (4) 876-895
8. Chatani, E.; Lee, Y.-H.; Yagi, H.; Yoshimura, Y.; Naiki, H.; Goto, Y. Ultrasonication-Dependent Production and Breakdown Lead to Minimum-Sized Amyloid Fibrils Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (27) 11119-11124
9. Arora, A.; Ha, C.; Park, C. B. Insulin Amyloid Fibrillation at above 100 C: New Insights into Protein Folding under Extreme Temperatures Protein Sci. 2004, 13 (9) 2429-2436
10. Dubois, J.; Ismail; Chan; Ali, K. Fourier Transform Infrared Spectroscopic Investigation of Temperature- and Pressure-Induced Disaggregation of Amyloid A Scand. J. Immunol. 1999, 49 (4) 376-380
11. Adamcik, J.; Mezzenga, R. Adjustable Twisting Periodic Pitch of Amyloid Fibrils Soft Matter 2011, 7 (11) 5437-5443
12. 2-Microglobulin Probed by Guanidine-Hydrochloride-Induced Unfolding FEBS Lett. 2004, 576 (3) 313-319
13. 2-Microglobulin Amyloid Fibrils by Dimethylsulfoxide J. Biochem. 2003, 134 (1) 159-164
14. Jordens, S.; Adamcik, J.; Amar-Yuli, I.; Mezzenga, R. Disassembly and Reassembly of Amyloid Fibrils in Water-Ethanol Mixtures Biomacromolecules 2010, 12 (1) 187-193
15. Li, J.; Zhu, M.; Manning-Bog, A. B.; Di Monte, D. A.; Fink, A. L. Dopamine and L-Dopa Disaggregate Amyloid Fibrils: Implications for Parkinson's and Alzheimer's Disease FASEB J. 2004, 18 (9) 962-964
16. Benilova, I.; Karran, E.; De Strooper, B. The toxic Aβ Oligomer and Alzheimer's Disease: An Emperor in Need of Clothes Nat. Neurosci. 2012, 15 (3) 349-357
17. Ruhs, P. A.; Adamcik, J.; Bolisetty, S.; Sanchez-Ferrer, A.; Mezzenga, R. A Supramolecular Bottle-Brush Approach to Disassemble Amyloid Fibrils Soft Matter 2011, 7 (7) 3571-3579
18. Park, J.-W.; Lee, I.-H.; Hahn, J.-S.; Kim, J.; Chung, K. C.; Paik, S. R. Disintegration of Amyloid Fibrils of α-Synuclein by Dequalinium Biochim. Biophys. Acta, Gen. Subj. 2008, 1780 (10) 1156-1161
19. Giorgetti, S.; Raimondi, S.; Pagano, K.; Relini, A.; Bucciantini, M.; Corazza, A.; Fogolari, F.; Codutti, L.; Salmona, M.; Mangione, P.; Colombo, L.; De Luigi, A.; Porcari, R.; Gliozzi, A.; Stefani, M.; Esposito, G.; Bellotti, V.; Stoppini, M. Effect of Tetracyclines on the Dynamics of Formation and Destructuration of β2-Microglobulin Amyloid Fibrils J. Biol. Chem. 2011, 286 (3) 2121-2131
20. Bieschke, J.; Russ, J.; Friedrich, R. P.; Ehrnhoefer, D. E.; Wobst, H.; Neugebauer, K.; Wanker, E. E. EGCG Remodels Mature α-Synuclein and Amyloid-β Fibrils and Reduces Cellular Toxicity Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (17) 7710-7715
21. Wong, H. E.; Qi, W.; Choi, H.-M.; Fernandez, E. J.; Kwon, I.; Safe, A. Blood-Brain Barrier Permeable Triphenylmethane Dye Inhibits Amyloid-β Neurotoxicity by Generating Nontoxic Aggregates ACS Chem. Neurosci. 2011, 2 (11) 645-657
22. Wong, H. E.; Kwon, I. Xanthene Food Dye, as a Modulator of Alzheimer's Disease Amyloid-β Peptide Aggregation and the Associated Impaired Neuronal Cell Function PLoS One 2011, 6 (10) e25752
23. Ladiwala, A. R. A.; Dordick, J. S.; Tessier, P. M. Aromatic Small Molecules Remodel Toxic Soluble Oligomers of Amyloid-β through Three Independent Pathways J. Biol. Chem. 2011, 286 (5) 3209-3218
24. Necula, M.; Breydo, L.; Milton, S.; Kayed, R.; van der Veer, W. E.; Tone, P.; Glabe, C. G. Methylene Blue Inhibits Amyloid Aβ Oligomerization by Promoting Fibrillization Biochemistry 2007, 46 (30) 8850-60
25. Callaway, N. L.; Riha, P. D.; Wrubel, K. M.; McCollum, D.; Gonzalez-Lima, F. Methylene Blue Restores Spatial Memory Retention Impaired by an Inhibitor of Cytochrome Oxidase in Rats Neurosci. Lett. 2002, 332 (2) 83-86
26. Korth, C.; May, B. C.; Cohen, F. E.; Prusiner, S. B. Acridine and Phenothiazine Derivatives As Pharmacotherapeutics for Prion Disease Proc. Natl. Acad. Sci. U.S.A. 2001, 98 (17) 9836-41
27. Borzelleca, J. F.; Hallagan, J. B. Multigeneration study of FD & C Red No. 3 (Erythrosine) in Sprague-Dawley rats Food Chem. Toxicol. 1990, 28 (12) 813-9
28. Levitan, H.; Ziylan, Z.; Smith, Q. R.; Takasato, Y.; Rapoport, S. I. Brain Uptake of a Food Dye, Erythrosin B, Prevented by Plasma Protein Binding Brain Res. 1984, 322 (1) 131-4
29. Shin, H.-J.; Lee, E.-K.; Lee, J.-H.; Lee, D.; Chang, C.-S.; Kim, Y.-S.; Paik, S. R. Eosin Interaction of α-Synuclein Leading to Protein Self-Oligomerization Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol. 2000, 1481 (1) 139-146
30. Gardner, D. F.; Utiger, R. D.; Schwartz, S. L.; Witorsch, P.; Meyers, B.; Braverman, L. E.; Witorsch, R. J. Effects of Oral Erythrosine (2′,4′,5′,7′-Tetraiodofluorescein) on Thyroid Function in Normal Men Toxicol. Appl. Pharmacol. 1987, 91 (3) 299-304
31. Hirohashi, T.; Terasaki, T.; Shigetoshi, M.; Sugiyama, Y. In Vivo and In Vitro Evidence for Nonrestricted Transport of 2′,7′-Bis(2- carboxyethyl)-5(6)-carboxyfluorescein Tetraacetoxymethyl Ester at the Blood-Brain Barrier J. Pharmacol. Exp. Ther. 1997, 280 (2) 813-819
32. Remy, M.; Thaler, S.; Schumann, R. G.; May, C. a.; Fiedorowicz, M.; Schuettauf, F.; Grüterich, M.; Priglinger, S. G.; Nentwich, M. M.; Kampik, A.; Haritoglou, C. An in Vivo Evaluation of Brilliant Blue G in Animals and Humans Br. J. Ophthalmol. 2008, 92 (8) 1142-7
33. Peng, W.; Cotrina, M. L.; Han, X.; Yu, H.; Bekar, L.; Blum, L.; Takano, T.; Tian, G.-F.; Goldman, S. A.; Nedergaard, M. Systemic Administration of an Antagonist of the ATP-Sensitive Receptor P2X7 Improves Recovery after Spinal Cord Injury Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (30) 12489-12493
34. Borzelleca Joseph, F.; Hallagan John, B. Safety and Regulatory Status of Food, Drug, and Cosmetic Color Additives. Food Safety Assessment; American Chemical Society: Washington, DC, 1992; Vol. 484, pp 377-390.
35. Borzelleca, J. F.; Depukat, K.; Hallagan, J. B. Lifetime Toxicity/Carcinogenicity Studies of FD & C Blue No. 1 (Brilliant Blue FCF) in Rats and Mice Food Chem. Toxicol. 1990, 28 (4) 221-234
36. Ryu, J. K.; McLarnon, J. G. Block of Purinergic P2X7 Receptor Is Neuroprotective in an Animal Model of Alzheimer's Disease NeuroReport 2008, 19 (17) 1715-1719
37. Matute, C.; Torre, I.; Pérez-Cerdá, F.; Pérez-Samartín, A.; Alberdi, E.; Etxebarria, E.; Arranz, A. M.; Ravid, R.; Rodríguez-Antigüedad, A.; Sánchez-Gómez, M.; Domercq, M. P2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis J. Neurosci. 2007, 27 (35) 9525-9533
38. Simmons, R.; Thevarajah, S.; Brennan, M.; Christos, P.; Osborne, M. Methylene Blue Dye as an Alternative to Isosulfan Blue Dye for Sentinel Lymph Node Localization Ann. Surg. Oncol. 2003, 10 (3) 242-247
39. Thevarajah, S.; Huston, T. L.; Simmons, R. M. A Comparison of the Adverse Reactions Associated with Isosulfan Blue versus Methylene Blue Dye in Sentinel Lymph Node Biopsy for Breast Cancer Am. J. Surg. 2005, 189 (2) 236-239
40. Zoungrana, A.; Coulibaly, B.; Sié, A.; Walter-Sack, I.; Mockenhaupt, F. P.; Kouyaté, B.; Schirmer, R. H.; Klose, C.; Mansmann, U.; Meissner, P.; Müller, O. Safety and Efficacy of Methylene Blue Combined with Artesunate or Amodiaquine for Uncomplicated Falciparum Malaria: A Randomized Controlled Trial from Burkina Faso PLoS One 2008, 3 (2) e1630
41. Medina, D. X.; Caccamo, A.; Oddo, S. Methylene Blue Reduces Aβ Levels and Rescues Early Cognitive Deficit by Increasing Proteasome Activity Brain Pathol. 2011, 21 (2) 140-149
42. Gwyddion Home Page. http://gwyddion.net/ (accessed August 27, 2012).
43. Whitmore, L.; Wallace, B. A. Protein Secondary Structure Analyses from Circular Dichroism Spectroscopy: Methods and Reference Databases Biopolymers 2008, 89 (5) 392-400
44. Provencher, S. W.; Gloeckner, J. Estimation of Globular Protein Secondary Structure from Circular Dichroism Biochemistry 1981, 20 (1) 33-37
45. Vanstokkum, I. Estimation of Protein Secondary Structure and Error Analysis from Circular Dichroism Spectra Anal. Biochem. 1990, 191 (1) 110-118
46. Sreerama, N.; Woody, R. W. Estimation of Protein Secondary Structure from Circular Dichroism Spectra: Comparison of CONTIN, SELCON, and CDSSTR Methods with an Expanded Reference Set Anal. Biochem. 2000, 287 (2) 252-260
47. Sreerama, N.; Venyaminov, S. Y.; Woody, R. W. Estimation of Protein Secondary Structure from Circular Dichroism Spectra: Inclusion of Denatured Proteins with Native Proteins in the Analysis Anal. Biochem. 2000, 287 (2) 243-251
48. Lees, J. G.; Miles, A. J.; Wien, F.; Wallace, B. A. A Reference Database for Circular Dichroism Spectroscopy Covering Fold and Secondary Structure Space Bioinformatics 2006, 22 (16) 1955-1962
49. Hudson, S. a.; Ecroyd, H.; Kee, T. W.; Carver, J. a. The Thioflavin T Fluorescence Assay for Amyloid Fibril Detection Can Be Biased by the Presence of Exogenous Compounds FEBS J. 2009, 276 (20) 5960-72
50. Del Mercato, L. L.; Maruccio, G.; Pompa, P. P.; Bochicchio, B.; Tamburro, A. M.; Cingolani, R.; Rinaldi, R. Amyloid-like Fibrils in Elastin-Related Polypeptides: Structural Characterization and Elastic Properties Biomacromolecules 2008, 9 (3) 796-803
51. Santos, S.; Barcons, V.; Christenson, H. K.; Font, J.; Thomson, N. H. The Intrinsic Resolution Limit in the Atomic Force Microscope: Implications for Heights of Nano-scale Features PLoS One 2011, 6 (8) e23821
52. Pires, R. H.; Saraiva, M. J.; Damas, A. M.; Kellermayer, M. S. Z. Structure and Assembly-Disassembly Properties of Wild-Type Transthyretin Amyloid Protofibrils Observed with Atomic Force Microscopy J. Mol. Recognit. 2011, 24 (3) 467-476
53. Stine, W. B.; Dahlgren, K. N.; Krafft, G. a.; LaDu, M. J. In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis J. Biol. Chem. 2003, 278 (13) 11612-22
54. Langkilde, A. E.; Vestergaard, B. Methods for Structural Characterization of Prefibrillar Intermediates and Amyloid Fibrils FEBS Lett. 2009, 583 (16) 2600-9
55. Schmidt, M.; Sachse, C.; Richter, W.; Xu, C.; Fändrich, M.; Grigorieff, N. Comparison of Alzheimer Aβ(1-40) and Aβ(1-42) Amyloid Fibrils Reveals Similar Protofilament Structures Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (47) 19813-19818
56. Woods, L. a.; Platt, G. W.; Hellewell, A. L.; Hewitt, E. W.; Homans, S. W.; Ashcroft, A. E.; Radford, S. E. Ligand Binding to Distinct States Diverts Aggregation of an Amyloid-Forming Protein Nat. Chem. Biol. 2011, 7 (10) 730-9
57. Ahmed, M.; Davis, J.; Aucoin, D.; Sato, T.; Ahuja, S.; Aimoto, S.; Elliott, J. I.; Van Nostrand, W. E.; Smith, S. O. Structural Conversion of Neurotoxic Amyloid-β(1-42) Oligomers to Fibrils Nat. Struct. Mol. Biol. 2010, 17 (5) 561-567
58. Chimon, S.; Shaibat, M. a.; Jones, C. R.; Calero, D. C.; Aizezi, B.; Ishii, Y. Evidence of Fibril-like β-Sheet Structures in a Neurotoxic Amyloid Intermediate of Alzheimer's β-Amyloid Nat. Struct. Mol. Biol. 2007, 14 (12) 1157-1164
59. Klement, K.; Wieligmann, K.; Meinhardt, J.; Hortschansky, P.; Richter, W.; Fändrich, M. Effect of Different Salt Ions on the Propensity of Aggregation and on the Structure of Alzheimer's Aβ(1-40) Amyloid Fibrils J. Mol. Biol. 2007, 373 (5) 1321-1333
60. Bartolini, M.; Bertucci, C.; Bolognesi, M. L.; Cavalli, A.; Melchiorre, C.; Andrisano, V. Insight into the Kinetic of Amyloid β (1-42) Peptide Self-Aggregation: Elucidation of Inhibitors' Mechanism of Action ChemBioChem 2007, 8 (17) 2152-61
61. Bitan, G.; Kirkitadze, M. D.; Lomakin, A.; Vollers, S. S.; Benedek, G. B.; Teplow, D. B. Amyloid β-Protein Assembly: Aβ40 and Aβ42 Oligomerize through Distinct Pathways Proc. Natl. Acad. Sci. U. S. A. 2003, 100 (1) 330-335
62. Harada, T.; Kuroda, R. CD Measurements of β-Amyloid (1-40) and (1-42) in the Condensed Phase Biopolymers 2011, 95 (2) 127-34
63. Soto, C.; Castaño, E. M.; Frangione, B.; Inestrosa, N. C. The α-Helical to β-Strand Transition in the Amino-Terminal Fragment of the Amyloid β-Peptide Modulates Amyloid Formation J. Biol. Chem. 1995, 270 (7) 3063-3067
64. Chen, Y.-R.; Glabe, C. G. Distinct Early Folding and Aggregation Properties of Alzheimer Amyloid-β Peptides Aβ40 and Aβ42 J. Biol. Chem. 2006, 281 (34) 24414-24422
65. Kayed, R.; Head, E.; Thompson, J. L.; McIntire, T. M.; Milton, S. C.; Cotman, C. W.; Glabe, C. G. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis Science 2003, 300 (5618) 486-9
66. Kayed, R.; Head, E.; Sarsoza, F.; Saing, T.; Cotman, C. W.; Necula, M.; Margol, L.; Wu, J.; Breydo, L.; Thompson, J. L.; Rasool, S.; Gurlo, T.; Butler, P.; Glabe, C. G. Fibril Specific, Conformation Dependent Antibodies Recognize a Generic Epitope Common to Amyloid Fibrils and Fibrillar Oligomers That Is Absent in Prefibrillar Oligomers Mol. Neurodegener. 2007, 2, 18
67. Wu, J. W.; Breydo, L.; Isas, J. M.; Lee, J.; Kuznetsov, Y. G.; Langen, R.; Glabe, C. Fibrillar Oligomers Nucleate the Oligomerization of Monomeric Amyloid Beta but Do Not Seed Fibril Formation J. Biol. Chem. 2010, 285 (9) 6071-9
68. Ladiwala, A. R. A.; Lin, J. C.; Bale, S. S.; Marcelino-Cruz, A. M.; Bhattacharya, M.; Dordick, J. S.; Tessier, P. M. Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Abeta into Off-Pathway Conformers J. Biol. Chem. 2010, 285 (31) 24228-24237
69. Hu, Y.; Su, B.; Kim, C.-S.; Hernandez, M.; Rostagno, A.; Ghiso, J.; Kim, J. R. A Strategy for Designing a Peptide Probe for Detection of β-Amyloid Oligomers ChemBioChem 2010, 11 (17) 2409-18
70. Williams, A. D.; Sega, M.; Chen, M.; Kheterpal, I.; Geva, M.; Berthelier, V.; Kaleta, D. T.; Cook, K. D.; Wetzel, R. Structural Properties of Aβ Protofibrils Stabilized by a Small Molecule Proc. Natl. Acad. Sci. U.S.A. 2005, 102 (20) 7115-7120
71. Iijima, K.; Liu, H. P.; Chiang, A. S.; Hearn, S. A.; Konsolaki, M.; Zhong, Y. Dissecting the Pathological Effects of Human Abeta40 and Abeta42 in Drosophila: A Potential Model for Alzheimer's Disease Proc. Natl. Acad. Sci. U. S. A. 2004, 101 (17) 6623-6628
72. Kimura, N.; Yanagisawa, K.; Terao, K.; Ono, F.; Sakakibara, I.; Ishii, Y.; Kyuwa, S.; Yoshikawa, Y. Age-Related Changes of Intracellular Abeta in Cynomolgus Monkey Brains Neuropathol. Appl. Neurobiol. 2005, 31 (2) 170-180
73. Klyubin, I.; Walsh, D. M.; Lemere, C. A.; Cullen, W. K.; Shankar, G. M.; Betts, V.; Spooner, E. T.; Jiang, L. Y.; Anwyl, R.; Selkoe, D. J.; Rowan, M. J. Amyloid Beta Protein Immunotherapy Neutralizes Abeta Oligomers That Disrupt Synaptic Plasticity in Vivo Nat. Med. (N. Y., NY, U. S.) 2005, 11 (5) 556-561
74. Thakker, D. R.; Weatherspoon, M. R.; Harrison, J.; Keene, T. E.; Lane, D. S.; Kaemmerer, W. F.; Stewart, G. R.; Shafer, L. L. Intracerebroventricular Amyloid-Beta Antibodies Reduce Cerebral Amyloid Angiopathy and Associated Micro-hemorrhages in Aged Tg2576 Mice Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (11) 4501-4506
75. Sarroukh, R.; Cerf, E.; Derclaye, S.; Dufreîne, Y.; Goormaghtigh, E.; Ruysschaert, J.-M.; Raussens, V. Transformation of Amyloid β(1-40) Oligomers into Fibrils Is Characterized by a Major Change in Secondary Structure Cell. Mol. Life Sci. 2011, 68 (8) 1429-1438
76. Greenfield, N. J. Using Circular Dichroism Spectra to Estimate Protein Secondary Structure Nat. Protoc. 2006, 1 (6) 2876-90